Sebastian Wingen-Heimann
6PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 26, 2025
Evaluating the health economic impact of cefepime/enmetazobactam in complicated urinary tract infections in the German setting: a cost analysis from payer perspective.Johanna Röder, Sebastian M Wingen-Heimann, Danila Seidel
|May 07, 2024
A retrospective budget impact analysis of fidaxomicin treatment for <i>Clostridioides difficile</i> infections (CDI) in Germany.Ann-Cathrine Siefen, Melina Sophie Kurte, Anna Marie Bauer
|Sep 19, 2023
Staphylococcus aureus surgical site infection rates in 5 European countries.Sibylle C Mellinghoff, Caroline Bruns, Markus Albertsmeier
|Jan 21, 2023
Health economic analysis of patients treated with isavuconazole in a German comprehensive cancer centre.Julia Jeck, Sebastian M Wingen-Heimann, Florian Jakobs
|Jun 16, 2021
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazole.Julia Jeck, Sebastian M Wingen-Heimann, Christian Thielscher
|Dec 23, 2020
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.Sebastian M Wingen-Heimann, Oliver A Cornely, Maria J G T Vehreschild
Pageof 1
Frequent Collaborators
6 joint publications
Oliver A Cornely
4 joint publications
Florian Kron
2 joint publications
Jörg Janne Vehreschild
2 joint publications
Julia Jeck
2 joint publications
Ann-Cathrine Siefen
2 joint publications
Melina Sophie Kurte
1 joint publications
Maria J G T Vehreschild
1 joint publications
Anna Kron
1 joint publications
Johanna Röder
1 joint publications
Danila Seidel
